Cytox, a University of Birmingham spin out, has relaunched with a custom-built laboratory, a new management team, and £3.5m ($5.5m) from new and existing backers. The UK-based biomedical firm went into administration 18 months ago. However, Cytox has now returned following new investments from fund manager SPARK Impact, life science fund Esperante, seed investor Wren…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
